Search All News
By participating in one of the world’s largest genetic studies, New Yorkers will help bring precision medicine to their communities, Columbia’s David Goldstein explains.
A new study finds that regulatory gene variants can affect the severity of a genetic disease among people with the same protein-coding mutation.
- January 30, 2015
Two Columbia University Medical Center faculty members were present today when President Obama provided details of the precision medicine initiative he announced during this year’s State of the Union address.
- January 9, 2015
Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches.
- December 22, 2014
People with autism have a wide range of symptoms, with no two people sharing the exact type and severity of behaviors. Now a large-scale analysis of hundreds of patients and nearly 1000 genes has started to uncover how diversity among traits can be traced to differences in patients’ genetic mutations.
- November 24, 2014
Columbia University Medical Center has presented Andrew Hattersley, DM, and Mark McCarthy, MD, with the 16th Naomi Berrie Award for Outstanding Research in Diabetes, for their work on the genetics of the disease.
- October 13, 2014
A puzzling form of kidney disease—IgA nephropathy—appears to spring from the intestine, says study by CUMC researchers.
- September 23, 2014
David Goldstein, PhD, will join Columbia University as professor of genetics and development in the College of Physicians and Surgeons and director of a new Institute for Genomic Medicine in partnership with NewYork-Presbyterian, effective January 1, 2015.
- September 15, 2014
A study that revealed the origins of the Askhenazi Jewish population will advance personalized medicine.
- August 17, 2014
Columbia researchers identify immune cells responsible for destroying hair follicles in people with alopecia areata and restore hair growth with an FDA-approved drug